Neoadjuvant chemotherapy for invasive bladder cancer: future directions.
Scher
H I
HI
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Splinter
T A
TA
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D002986:Clinical Trials as Topic / Q000379:methods; D004351:Drug Resistance; D005544:Forecasting; D006801:Humans; D009361:Neoplasm Invasiveness; D001749:Urinary Bladder Neoplasms / Q000145:classification / Q000188:drug therapy*
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor